U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599761) titled 'A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants' on May 07.
Brief Summary: The objective of this study is to assess the effect of repeated doses of itraconazole on the single dose pharmacokinetics (PK) of ABBV-722.
Study Start Date: May 05
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ABBV-722
Oral Tablet
DRUG: Itraconazole
Oral Capsule
Recruitment Status: RECRUITING
Sponsor: AbbVie
Disclaimer: Curated by HT Syndication....